Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement.
Zhou N, Li T, Liang M, Ren F, Ni H, Liu W, Shi T, Xu D, Chen Q, Yu H, Song Z, Zu L, Li S, Xu S.
Zhou N, et al. Among authors: chen q.
Front Oncol. 2022 Feb 10;12:848779. doi: 10.3389/fonc.2022.848779. eCollection 2022.
Front Oncol. 2022.
PMID: 35223529
Free PMC article.